Literature DB >> 26682779

Hypertension is associated with dysfunction of both peripheral and central auditory system.

Tomasz Przewoźny1, Anna Gójska-Grymajło, Mariusz Kwarciany, Beata Graff, Tomasz Szmuda, Dariusz Gąsecki, Krzysztof Narkiewicz.   

Abstract

OBJECTIVES: Arterial hypertension negatively influences the peripheral auditory system, causing sensorineural hearing loss. Much less is known about the detrimental effects of hypertension on the central auditory functions.
METHODS: We tested 32 arterial hypertension patients and 32 age and sex-matched healthy volunteers with the expanded tonal audiometry (0.125-12.5 kHz), distortion product otoacoustic emissions (0.75-8 kHz), horizontal minimum audible angle test for eight azimuths with binaural stimulation and the random gap detection test.
RESULTS: Peripheral hearing of the hypertensive patients was impaired in comparison with the controls within all audiometric frequencies (0.125-12.5 kHz) and within specific groups of frequencies. Distortion product otoacoustic emission results were significantly lower for frequencies 4 (P = 0.04) and 6 kHz (P < 0.001). The sound localization ability in the horizontal minimum audible angle test was significantly worse in the hypertensive patients in the 0°, 45°, 90°, 135°, and 270° azimuth when the interaural pure tone average (0.5-1-2 kHz) was set less than 20 dB hearing level (P < 0.05), and in the 0°, 90°, 225°, and 270°azimuth when the binaural pure tone average (0.5-1-2 kHz) was set 20 dB or less hearing level (P < 0.05). Gap detection thresholds in the random gap detection test did not differ between the two groups.
CONCLUSION: Arterial hypertension is independently related to the damage of the peripheral part of the auditory system resulting in high-frequency hearing loss. Hypertensive disturbances of central auditory processing are more discrete and concern the spatial hearing resolution.

Entities:  

Mesh:

Year:  2016        PMID: 26682779     DOI: 10.1097/HJH.0000000000000803

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  5 in total

1.  The Sound of Silence: A Proxy for Platinum Toxicity.

Authors:  Jan Oldenburg; Jourik A Gietema
Journal:  J Clin Oncol       Date:  2016-07-05       Impact factor: 44.544

2.  Association of Cardiovascular Comorbidities With Hearing Loss in the Older Old.

Authors:  Kapil Wattamwar; Z Jason Qian; Jenna Otter; Matthew J Leskowitz; Francesco F Caruana; Barbara Siedlecki; Jaclyn B Spitzer; Anil K Lalwani
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-07-01       Impact factor: 6.223

3.  Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments.

Authors:  Shirin Ardeshirrouhanifard; Sophie D Fossa; Robert Huddart; Patrick O Monahan; Chunkit Fung; Yiqing Song; M Eileen Dolan; Darren R Feldman; Robert J Hamilton; David Vaughn; Neil E Martin; Christian Kollmannsberger; Paul Dinh; Lawrence Einhorn; Robert D Frisina; Lois B Travis
Journal:  Ear Hear       Date:  2022 May/Jun       Impact factor: 3.562

Review 4.  The influence of metabolic syndrome on age-related hearing loss from the perspective of mitochondrial dysfunction.

Authors:  Dongye Guo; Andi Zhang; Tianyuan Zou; Rui Ding; Kaili Chen; Yi Pan; Peilin Ji; Bin Ye; Mingliang Xiang
Journal:  Front Aging Neurosci       Date:  2022-07-29       Impact factor: 5.702

5.  Longitudinal Blood Pressure Patterns From Mid- to Late Life and Late-Life Hearing Loss in the Atherosclerosis Risk in Communities Study.

Authors:  James Ting; Kening Jiang; Simo Du; Joshua Betz; Nicholas Reed; Melinda C Power; Rebecca Gottesman; A Richey Sharrett; Michael Griswold; Keenan A Walker; Edgar R Miller; Frank R Lin; Jennifer A Deal
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-03-03       Impact factor: 6.591

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.